On November 7, 2025, China Resources Medical Holdings Company Limited (the “Company,” stock code: 1515) announced that Mr. Zhang Chuang has been appointed as an executive Director and the Chief Executive Officer (CEO), and Mr. Wu Xinchun has been appointed as an executive Director. Concurrently, Mr. Yu Hai has resigned as CEO due to a change in work arrangements, but will continue to serve as an executive Director and chairman of the board.
Mr. Zhang, aged 48, currently serves as general manager and a director of CR Healthcare, the Company’s controlling shareholder. He held roles from assistant general manager to deputy general manager at CR Healthcare from September 2014 to June 2025. Previously, he served at China Worldbest Group Co., Ltd.*; Sanjiu Enterprise Group*; and China Resources Pharmaceutical Group Limited in positions including office manager, secretary to the president, and assistant general manager. He also held roles at Shenzhen China Resources Petrochemical Investment and Development Co., Ltd.* between January 2003 and April 2007. Mr. Zhang holds a bachelor’s degree in engineering from the Beijing Institute of Petrochemical Technology and has the title of intermediate economist.
Mr. Wu, aged 55, has been vice president of the Company since December 2018. He is currently the deputy general manager of CR Healthcare and also serves as a director of certain Company subsidiaries. His past positions include assistant to the general manager of Wuhan Iron and Steel Group Co., Ltd.*, executive director and general manager of Wugang Modern City Services Group Co., Ltd.*, and chairman of China Resources Wuhan Iron and Steel Medical Management Co., Ltd.*. He has also served at the China Iron and Steel Association and Wuhan Iron and Steel Group in technical, innovation, and information management roles. Mr. Wu holds a doctoral degree in engineering from Wuhan University of Technology and is a senior engineer at the professor level.
Each of Mr. Zhang and Mr. Wu has entered into a three-year service agreement with the Company, effective from November 7, 2025 to November 6, 2028. Their remuneration will be determined by the Company’s board and its remuneration committee, referencing market conditions and their responsibilities. Mr. Zhang is entitled to a pre-tax basic monthly salary of RMB65,000, while Mr. Wu is entitled to a pre-tax basic monthly salary of RMB59,500. Both are eligible for discretionary bonuses at the decision of the board and the remuneration committee. As of the date of the announcement, Mr. Zhang holds 260,000 shares in China Resources Building Materials Technology Holdings Limited (stock code: 1313), while Mr. Wu holds 140,230 shares of the Company (approximately 0.01% of the Company’s issued share capital).
According to the announcement, Mr. Yu has confirmed he has no disagreement with the board regarding his resignation as CEO and that there are no matters needing to be brought to shareholders’ attention. Following the appointment of Mr. Zhang as CEO, the Company reports it has complied with Code Provision C.2.1 of Part 2 of the Corporate Governance Code. The board expressed its gratitude to Mr. Yu for his contributions and extended a warm welcome to Mr. Zhang and Mr. Wu in their new roles.
As of the date of the announcement and after the above changes, the Company’s board consists of four executive Directors (Mr. Yu Hai, Mr. Zhang Chuang, Mr. Wu Xinchun, and Ms. Yang Min), one non-executive Director (Ms. Ge Lu), and four independent non-executive Directors (Mr. Wu Ting Yuk, Anthony, Mr. Fu Tingmei, Mr. Zhou Peng, and Ms. Lo Wing Sze).